Hologic to acquire Cynosure for $1.65 billion

Hologic has signed a definitive agreement to acquire all outstanding shares of Cynosure for $66.00 per share in cash, corresponding to an equity value of approximately $1.65 billion and an enterprise value of $1.44 billion net of cash.

“Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses”sec.gov

• 3 sources
• sec.govEX-99.1Feb 14, 2017
• biospace.comHologic Takes Out Cynosure in $1.65 Billion Deal - BioSpaceBioSpace Editorial StaffFeb 14, 2017
• prnewswire.comHologic Completes Acquisition of CynosureHologic, Inc.Mar 22, 2017

Summarized from public sources; check the original articles before acting on it.